FS50150313: Difference between revisions

From FOIwiki
Jump to navigationJump to search
CSV import
 
XML import
Line 1: Line 1:
{{DNSummaryBox
{{DNSummaryBox
|dn_ref=FS50150313
|dn_ref=FS50150313
|dn_date=11/03/2010
|dn_date=11/03/2010
Line 7: Line 7:
}}
}}
{{DNDecision
{{DNDecision
|1=FOI 40
|dnd_section=FOI 10
|2=Partly Upheld
|dnd_finding=Upheld
}}
{{DNDecision
|dnd_section=FOI 17
|dnd_finding=Upheld
}}
{{DNDecision
|dnd_section=FOI 37
|dnd_finding=Not upheld
}}
{{DNDecision
|dnd_section=FOI 40
|dnd_finding=Partly Upheld
}}
}}

Revision as of 13:30, 3 May 2010


Decision Summary

  • Case Ref: FS50150313
  • Date: 11/03/2010
  • Public Authority: Medicines and Healthcare Products Regulatory Agency
  • Summary: The complainant sought correspondence exchanged between the public authority and The Prince of Wales (and those who represent him) concerning the regulation of homeopathic or herbal medicines. The public authority refused to disclose the majority of this information on the basis that it was exempt from disclosure on the basis of sections 37(1)(a) and 41(1) of the Act. The Commissioner has concluded that the public authority were entitled to withhold this information on the basis of section 37(1)(a) of the Act.
  • View PDF of Decision Notice: [1]